Therapeutic Research Programmes
GreenLight Medicines Ltd. currently has 9 therapeutic research and development programmes based across 4 research intensive universities in Ireland and the UK. We have carefully selected the very best research groups to conduct pre-clinical research across the 3 core disease areas we target:
- Cancers including prostate, ovarian and breast,
- Neurological conditions including epilepsy, alzheimers and addiction, and
- Inflammatory or immune related conditions including arthritis and arthritis-related depression, eye disease and diabetes
In early 2019 we have also established a plant biology programme to breed strains of plants with optimal mixtures of compounds. We plan to open a dedicated laboratory by mid 2019 to purify and screen compound mixtures, prior to pre-clinical testing in each research programme.
To date investment in research including co-funder contributions is € 3.26 million, with € 1. 25 million vested directly by GreenLight Medicines Ltd. The following sections provide brief scientific highlights from some of the ongoing research programmes and those that are set to launch in early 2019.